Publication | Closed Access

Inhibition of Telomerase Activity by PKC Inhibitors in Human Nasopharyngeal Cancer Cells in Culture

OncologyChemoprevention StrategyOncogenic AgentMedicineTelomerase ActivityPharmacologyCell DeathAnti-cancer AgentTumor SuppressorCancer BiologyCell BiologyCancer ResearchTumor BiologyPkc Inhibitors